Since both genes are highly expressed by neural cells, notably oligodendrocytes, the authors suggested then that rs10191329 impacts MS severity via the transcriptional regulation of ZNF638 and DYSF in neural cells [4]. This evidence concerns the gene ZNF638 and myeloid sarcoma.